Comparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50 within primary care

British Journal of Cancer · Published 2026-08-04 · DOI 10.1038/s41416-026-03547-2

Free full text

Authors (6)

Reuben Frost, Lorenzo Ficorella, Amy Berrington de Gonzalez, Antonis C. Antoniou, Montserrat García-Closas, Juliet A. Usher-Smith

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Frost, R., Ficorella, L., Gonzalez, A., et al. (2026). Comparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50 within primary care. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03547-2

Related articles

• Priorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment · British Journal of Cancer · 2026 · Cites or is cited by this article · Same journal
• Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinoma · British Journal of Cancer · 2026 · Same journal
• High KPNA2 expression predicts poor prognosis in pathological T4 colorectal cancer by importing c-Myc into the nucleus to suppress p53-dependent p21 expression · British Journal of Cancer · 2026 · Same journal
• Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial · British Journal of Cancer · 2026 · Same journal
• Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells · British Journal of Cancer · 2026 · Same journal
• Interpreting the adverse esophageal and colorectal findings in the Cancer Risk in Vegetarians Consortium · British Journal of Cancer · 2026 · Same journal
• AKR1B10 as a serum marker for diagnosis and postoperative monitoring of hepatocellular carcinoma · British Journal of Cancer · 2026 · Same journal
• Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies · British Journal of Cancer · 2026 · Same journal
• Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis · British Journal of Cancer · 2026 · Same journal
• Signatures of micropeptides encoded by lncRNAs in cancer progression and metastasis · British Journal of Cancer · 2026 · Same journal